Ignite Creation Date:
2025-12-24 @ 3:35 PM
Ignite Modification Date:
2026-01-01 @ 12:37 PM
Study NCT ID:
NCT01191892
Status:
COMPLETED
Last Update Posted:
2019-05-16
First Post:
2010-08-29
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Carboplatin and Gemcitabine Hydrochloride With or Without Vandetanib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Urinary Tract Cancer
Sponsor:
Cardiff University
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
CDR0000684016
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None